Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert


Search Title by author or title

Topical therapy with presbyopia eye drops (FOVtears) as a rescue treatment for refractive surgery unhappy patients

Poster Details

First Author: V.Vargas SPAIN

Co Author(s):    J. Alio   D. Romero   F. Vejarano              

Abstract Details


The aim of this study is to analyze if there is any improvement in near visual acuity and vision quality with a novel topical therapy (Pilocarpine 0.247%, Phenylephrine 0.78%, Nepafenac 0.023%, Pheniramine 0.034%, Naphazoline 0.003% and Polyethylenglycol 0.09%) in patients that are not pleased with their refractive surgery result.


Vissum Alicante, Spain


This is an interventional prospective study, 16 eyes of 8 patients who had previous refractive surgery (PresbyLASIK, HP LASIK, Intracorneal inlays, Multifocal IOL) were included; they were given one drop of the new therapy every 8 hours. The main outcomes measures included: uncorrected, corrected distance visual acuity and best corrected far-near visual acuity, were assessed prior to the administration of the eye drop and 2 weeks post-administration. Also, patients answered a satisfaction survey.


87.5% of the patients gained 1 line of binocular near vision, 37.5% gained two lines of near vision, best corrected distance visual acuity remain 1.0 (decimal) in all patients. 25% of the patients complained of mild headaches, and it was relieved with an oral NSAID, there wasn�â�€�™t any ocular side effect of the installation of the eye drop. 100% of the patients will recommend the treatment to others, and all of them were satisfied with their visual outcome after using the topical therapy. No case reported complications.


Patients were satisfied with their vision outcome.Treatment with FOVtears as a rescue treatment for patients unsatisfied with their outcomes after corneal refractive surgery offers a new alternative in refractive surgery participative management of non-satisfied patients.

Financial Disclosure:

gains financially from product or procedure presented

Back to Poster listing